BAXTER ISSUES VOLUNTARY NATIONWIDE RECALL OF CEFAZOLIN IN DEXTROSE INJECTION, USP, 2G / 100ML (20MG / ML) SINGLE-DOSE INFUSION BAG IN 100ML DUE TO PARTICULATE MATTER FOUND IN SOLUTION

U.S. FDA Recalls — July 24, 2026 – DEERFIELD, Ill., Baxter International Inc. (NYSE:BAX) is voluntarily recalling Lot LD175708, Exp 14-Feb 2027 of Cefazolin in Dextrose Injection due to a report of particulate matter found in the solution identified as cardboard.
Risk Statement: The use of the defective product has a

Read the original at U.S. FDA Recalls ↗

Auto-published by the finit.news Events monitor from U.S. FDA Recalls; summarized by AI and may contain errors — verify against the primary source. July 26, 2026.